NasdaqGS:TXGLife Sciences
10x Genomics (TXG) Is Up 9.7% After Momentum Rally Despite Weak Fundamentals - What's Changed
In recent days, 10x Genomics experienced an extended winning streak in its stock, lifting its market value by about US$1.10 billion even as commentators highlighted ongoing weakness in operating performance and financial condition.
This sharp rerating, coming despite concerns about fundamentals and valuation, raises questions about how much of the positive sentiment is grounded in the company’s underlying business trajectory.
We’ll now examine how this momentum-driven rally, despite weak...